Search Results
Aug 13, 2026, 07:28 ET FREELANDER Reaches a New Milestone as FREELANDER 8 Enters Mass Production for China
FREELANDERFREELANDER is a British Premium Intelligent All-Terrain brand co-developed by Chery and Jaguar Land Rover. JLR leads the design and premium DNA, while Chery brings advanced technology and global top-tier supply chain capabilities. The brand is supported by a strong global foundation.
More news about: FREELANDER
Aug 13, 2026, 07:20 ET FREELANDER Reaches a New Milestone as FREELANDER 8 Enters Mass Production for China
FREELANDERFREELANDER is a British Premium Intelligent All-Terrain brand co-developed by Chery and Jaguar Land Rover. JLR leads the design and premium DNA, while Chery brings advanced technology and global top-tier supply chain capabilities. The brand is supported by a strong global foundation.
More news about: FREELANDER
Aug 12, 2026, 16:05 ET INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights
investigational DNA immunotherapy developed for diseases associated with high-risk human papillomavirus (HPV) types 16 and 18.Next-Generation DNA Medicine Candidates INOVIO presented promising data from our next-generation DNA-Encoded Monoclonal Antibody (DMAb™) and DNA-Encoded Protein
More news about: INOVIO Pharmaceuticals, Inc.
Aug 12, 2026, 09:00 ET ScrubaDub's Award-Winning Workplace Culture Earns National and Regional Recognition
Community Servings kitchen and the Cradles to Crayons Giving Factory because giving back to the 20+ communities we serve across New England is part of our DNA," Paisner said.To celebrate its employees during this milestone anniversary year, ScrubaDub will host its annual Culture Week during the
More news about: ScrubaDub
Aug 12, 2026, 08:01 ET Japan and Mexico Patent Offices Both Grant Acurx Pharmaceuticals New Patents for DNA Polymerase IIIC Inhibitor Antibiotics
antibiotic candidates with a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram+ specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that
More news about: Acurx Pharmaceuticals, Inc.
Aug 12, 2026, 06:05 ET RyboDyn Unveils a Hidden Human Proteome and a New Universe of Actionable Cancer Targets
contains a high level of sequence homology to proteins expressed by distant organisms from the same locus, especially across the evolutionarily conserved DNA-binding domain. This cryptic open reading frame (ORF) gives rise to a tumor-restricted pMHC, representing an entirely new therapeutic handle on a well-known
More news about: RyboDyn
Aug 12, 2026, 03:01 ET Senhwa's CX-5461 Opens a New Frontier in Photoimmunotherapy; Multinational Study Published in Nucleic Acids Research
photodynamic therapy and photoimmunotherapy in addition to its established research profile involving G-quadruplex (G4) targeting and DNA-damage-related mechanisms. The study opens a potential new development path for this clinical-stage asset.
More news about: SENHWA BIOSCIENCES, INC.
Aug 11, 2026, 11:40 ET Unlocking High-Quality NGS Data from Challenging Clinical Samples, Upcoming Webinar Hosted by Xtalks
TORONTO, Aug. 11, 2026 /PRNewswire/ -- Extracting meaningful multi-omic insights from DNA and RNA sequencing data generated from challenging clinical specimens remains a common obstacle in biomarker-driven research and clinical trials. In
More news about: Xtalks
Aug 11, 2026, 10:00 ET MDA Space Opens MDA CHORUS™ Control Centre in Québec
vision into an achievable mission — bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For
More news about: MDA Space
Aug 11, 2026, 09:45 ET NIAID Awards Zepto Life Technology Contract Valued at Up to $8.9 Million to Advance the First Deployable Liquid Biopsy Platform for Infectious Disease
the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to advance its plasma cell-free DNA liquid biopsy platform for invasive fungal infections.
More news about: Zepto Life Technology
Aug 11, 2026, 05:56 ET NUS researchers achieve breakthrough in engineering colour-sensing yeast
mammalian cells into a single red light-responsive protein for yeast, which they named y-iLight. When exposed to red light, y-iLight attaches to certain DNA sequence in the yeast and turns on specific genes. Importantly, y-iLight works without the need for additional chemicals beyond those naturally found
More news about: National University of Singapore
Aug 10, 2026, 15:25 ET Greenberg Traurig to Relocate to Related Ross's 15 CityPlace, Reinforcing Longstanding Commitment to West Palm Beach
and upcoming new hires, coupled with this new space commitment, exhibit the adaptation to change that has long been an essential part of the firm's DNA.
More news about: Greenberg Traurig, LLP
Aug 10, 2026, 12:38 ET Boehringer Ingelheim Spotlights Next Generation of Veterinary Researchers
mechanistic insight into how differences in the maternal gut microbiome alter fetal neurodevelopment through changes in gut metabolite production, hippocampal DNA methylation, and gene expression. These findings advance our understanding of how the parental gut microbiome can influence lifelong health in the next
More news about: Boehringer Ingelheim Animal Health USA Inc.
Aug 10, 2026, 08:01 ET Acurx Announces Scientific Partnership with Leiden University Medical Center to Advance Development of Acurx's DNA Polymerase IIIC Inhibitor Antibiotics
University Medical Center and Acurx for DNA pol IIIC Inhibitors included detailed three-dimensional structures for three poI IIIC complexes from Enterococcus and was published in Nature Communications in 2025 [A unique inhibitor conformation selectively targets the DNA polymerase PolC of Gram-positive priority
More news about: Acurx Pharmaceuticals, Inc.
Aug 10, 2026, 07:00 ET Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma
qualitative next generation sequencing-based in vitro diagnostic device that uses a high-throughput hybridization-based capture technology utilizing DNA isolated from formalin-fixed paraffin embedded tumor tissue. The PGDx elio tissue complete CDx targeted panel can detect single nucleotide variants,
More news about: Labcorp
Aug 10, 2026, 05:27 ET Dx&Vx Signs Two Material Transfer Agreements in Latin America Within Two Months -- "Technology Validated Across Both Public and Private Sectors"
". The platform applies to a wide range of nucleic acid-based modalities, including mRNA vaccines, RNA-based therapeutics, DNA vaccines, aptamers, gene therapies, and gene-editing tools. Once material transfer is complete, partners conduct their own stability testing under internal
More news about: Dx&Vx
Aug 07, 2026, 13:54 ET The Inner Circle acknowledges Clinton Jones as a Pinnacle Professional Member Inner Circle of Excellence
Jones, a nationally recognized leader in virology, has served at Oklahoma State University (OSU) since 2015, where he leads groundbreaking research on DNA viruses and viral pathogenesis. His laboratory's work has advanced the global understanding of herpesvirus latency and reactivation, with particular
More news about: The Inner Circle
Aug 07, 2026, 10:57 ET Renew Biotechnologies Publishes Peer-Reviewed Research Advancing Cell-Type-Associated Biomarkers of Neurodegeneration
Frontiers in Neurology, providing evidence that native DNA methylation analysis can identify neuron-associated cell-free DNA (cfDNA) signatures in blood across Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis
More news about: Renew Biotechnologies
Aug 07, 2026, 06:00 ET MDA SPACE APPOINTS JOHN FARRELL & STEPHEN SPENGLER TO ITS BOARD OF DIRECTORS
vision into an achievable mission — bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For
More news about: MDA Space
Aug 07, 2026, 05:45 ET MDA SPACE REPORTS SECOND QUARTER 2026 RESULTS
vision into an achievable mission – bringing to bear a one-of- a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For
More news about: MDA Space
Aug 06, 2026, 17:09 ET MDA SPACE RESPONDS TO CANADIAN SPACE AGENCY ANNOUNCEMENT ON CANADARM3
vision into an achievable mission — bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For
More news about: MDA Space
Aug 06, 2026, 11:11 ET Spencer Spirit Holdings, Inc. to Acquire Hot Topic, Inc. to Combine Six Iconic Merchandise Concepts
growth, deepen licensor and vendor partnerships, and expand real estate opportunities across their combined footprint.To preserve the distinct DNA, culture, and operational strength of each brand, after closing, Hot Topic, BoxLunch and Her Universe will continue to operate independently from the
More news about: Sycamore Partners
Aug 06, 2026, 10:10 ET Neon Growth, MagBak, and Marpipe Launch First Enhanced Image Ads on Google Shopping
Our shopping ads now match that standard and have an opportunity to capture the right person in a crowded space. Being a first-mover is in our brand DNA."Read more details on the results and methodology at
More news about: Neon Growth
Aug 06, 2026, 10:00 ET OUTCAST PARTNERS WITH SPLASH HOUSE AND PORTOLA FESTIVALS TO EXPAND ITS LE CLUB OUTCAST EXPERIENCE ACROSS CALIFORNIA
its signature Le Club Outcast experience to two of the country's most celebrated music festivals. Festival season has been a core part of Outcast's DNA, as a brand rooted in the intersection of fashion, music, and nightlife.
More news about: Outcast Clothing
Aug 06, 2026, 09:30 ET Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test
diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to
More news about: Co-Diagnostics